|
|
|
|
MC809
Neuroblastoma and retinoblastoma tissue array, with TNM and grade info, 80 cases/80 cores, replaced by MC809a
|
|
| Microarray Panel: | Blastoma and normal tissue microarray, containing 2 cases of lymphoblastoma, 6 hemangioblastoma, 5 myofibroblastoma, 5 neuroblastoma, 22 nephroblastoma, 10 glioblastoma, 15 medulloblastoma, 2 each of ependymoblastoma and retinoblastoma, 1 gynandroblastoma and 10 normal tissue, sigle core per case |
| Cores: | 80 |
|
| Cases: | 80 |
| Layout: | 10 cols × 8 rows |
| Core Diameter: | 1.5 mm |
| Thickness: | 5 µm | | Quality Control: | Anti-Actin confirmed | | Applications: | Routine histology procedures including ImmunoHistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found on our support page. |
| Notes: | Unless specified, all TMA slides are not coated with extra layer of paraffin (tissue cores can be easily seen on the glass), so there is no need to bake, can be directly put into xylene for de-paraffin procedure. |
*Tissue Microarray Slide Types:
- Unstained: unstained
paraffin
tissue microarray slide.
- Trial: tissue microarray trial slide. 10% - 25% of cores missing. Good for titrating antibody dilution and experiment conditions. Limited numbers are available, to 2 per item per order. Test slides (tissue arrays with catalog numbers ending with 241 or 242) are recommended as a substitute.
- H & E: Hematoxylin and Eosin stained tissue microarray slide.
Microarray Panel Display  | | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | |
| A |
|
|
|
|
|
|
|
|
|
|
|
| B |
|
|
|
|
|
|
|
|
|
|
|
| C |
|
|
|
|
|
|
|
|
|
|
|
| D |
|
|
|
|
|
|
|
|
|
|
|
| E |
|
|
|
|
|
|
|
|
|
|
|
| F |
|
|
|
|
|
|
|
|
|
|
|
| G |
|
|
|
|
|
|
|
|
|
|
|
| H |
|
|
|
|
|
|
|
|
|
|
 |
|
| Legend: | Abd - Abdominal cavity,
Bra - Brain,
Cer - Cerebellum,
Col - Colon,
Eye - Eyeball,
Kid - Kidney,
Lym - Lymph node,
Med - Mediastinum,
Mes - Mesentery,
Ova - Ovary,
Pel - Pelvic cavity,
Ret - Retroperitoneum
- Malignant tumor,
- Malignant tumor,
- Malignant tumor (stage I),
- Malignant tumor (stage II),
- Malignant tumor (stage III),
- Malignant tumor (stage IIIa),
- Malignant tumor (stage IIIb),
- Malignant tumor (stage IIc),
- Malignant tumor (stage Ib),
- Malignant tumor (stage VI),
- Malignant tumor (stage VIa),
- Normal tissue
|
Specification Sheet
| Pos |
No. |
Sex |
Age |
Organ |
Pathology diagnosis |
Grade |
Stage |
TNM |
Type † |
|
A1 |
1 |
M |
8 |
Lymph node |
T lymphoblastoma of right groin |
– |
– |
– |
Malignant |
|
A2 |
2 |
F |
54 |
Lymph node |
B lymphoblastoma of left neck |
– |
– |
– |
Malignant |
|
A3 |
3 |
M |
37 |
Cerebellum |
Hemangioblastoma of cerebellum |
– |
– |
– |
Malignant |
|
A4 |
4 |
M |
52 |
Cerebellum |
Hemangioblastoma of cerebellum |
– |
– |
– |
Malignant |
|
A5 |
5 |
M |
38 |
Cerebellum |
Hemangioblastoma of cerebellum |
– |
– |
– |
Malignant |
|
A6 |
6 |
F |
35 |
Cerebellum |
Hemangioblastoma of cerebellum |
– |
– |
– |
Malignant |
|
A7 |
7 |
M |
70 |
Brain |
Hemangioblastoma |
– |
– |
– |
Malignant |
|
A8 |
8 |
M |
40 |
Cerebellum |
Hemangioblastoma of cerebellum |
– |
– |
– |
Malignant |
|
A9 |
9 |
M |
48 |
Mesentery |
Myofibroblastoma (low grade) |
– |
Ib |
T2bN0M0 |
Malignant |
|
A10 |
10 |
M |
40 |
Pelvic cavity |
Inflammatory myofibroblastoma (low grade) |
– |
Ib |
T2N0M0 |
Malignant |
|
B1 |
11 |
F |
26 |
Colon |
Inflammatory myofibroblastoma (low grade) |
– |
Ib |
T2bN0M0 |
Malignant |
|
B2 |
12 |
F |
45 |
Mediastinum |
Inflammatory myofibroblastoma (low grade) |
– |
Ib |
T2bN0M0 |
Malignant |
|
B3 |
13 |
M |
56 |
Mesentery |
Inflammatory myofibroblastoma (low grade) |
– |
Ib |
T2bN0M0 |
Malignant |
|
B4 |
14 |
F |
25 |
Abdominal cavity |
Neuroblastoma |
– |
IIIb |
T2N0M0 |
Malignant |
|
B5 |
15 |
M |
1 |
Mediastinum |
Neuroblastoma |
– |
IIIa |
T1bN0M0 |
Malignant |
|
B6 |
16 |
F |
25 |
Pelvic cavity |
Neuroblastoma |
– |
IIIb |
T2bN0M0 |
Malignant |
|
B7 |
17 |
M |
18 |
Retroperitoneum |
Neuroblastoma |
– |
VIa |
T2bN1M0 |
Malignant |
|
B8 |
18 |
F |
1 |
Retroperitoneum |
Neuroblastoma |
– |
IIIb |
T2bN0M0 |
Malignant |
|
B9 |
19 |
M |
8 |
Kidney |
Nephroblastoma |
– |
II |
T2N0M0 |
Malignant |
|
B10 |
20 |
M |
3 |
Kidney |
Nephroblastoma |
– |
II |
T2N0M0 |
Malignant |
|
C1 |
21 |
F |
4 |
Kidney |
Nephroblastoma |
– |
VI |
T4N0M0 |
Malignant |
|
C2 |
22 |
M |
8 |
Kidney |
Nephroblastoma |
– |
I |
T1N0M0 |
Malignant |
|
C3 |
23 |
F |
35 |
Kidney |
Nephroblastoma |
– |
I |
T1N0M0 |
Malignant |
|
C4 |
24 |
F |
3 |
Kidney |
Nephroblastoma |
– |
I |
T1N0M0 |
Malignant |
|
C5 |
25 |
M |
26 |
Kidney |
Nephroblastoma |
– |
II |
T2N0M0 |
Malignant |
|
C6 |
26 |
M |
51 |
Kidney |
Nephroblastoma |
– |
I |
T1N0M0 |
Malignant |
|
C7 |
27 |
F |
14 |
Kidney |
Nephroblastoma |
– |
II |
T2N0M0 |
Malignant |
|
C8 |
28 |
M |
4 |
Kidney |
Nephroblastoma |
– |
II |
T2N0M0 |
Malignant |
|
C9 |
29 |
F |
4 |
Kidney |
Nephroblastoma |
– |
I |
T1N0M0 |
Malignant |
|
C10 |
30 |
M |
|
Kidney |
Nephroblastoma |
– |
III |
T3aN0M0 |
Malignant |
|
D1 |
31 |
M |
25 |
Kidney |
Nephroblastoma |
– |
I |
T1N0M0 |
Malignant |
|
D2 |
32 |
F |
5 |
Kidney |
Nephroblastoma |
– |
I |
T1N0M0 |
Malignant |
|
D3 |
33 |
F |
7 |
Kidney |
Nephroblastoma |
– |
III |
T3N0M0 |
Malignant |
|
D4 |
34 |
M |
2 |
Kidney |
Nephroblastoma |
– |
II |
T2N0M0 |
Malignant |
|
D5 |
35 |
F |
2 |
Kidney |
Nephroblastoma |
– |
II |
T2N0M0 |
Malignant |
|
D6 |
36 |
F |
3 |
Kidney |
Nephroblastoma |
– |
II |
T2N0M0 |
Malignant |
|
D7 |
37 |
F |
4 |
Kidney |
Nephroblastoma |
– |
II |
T2N0M0 |
Malignant |
|
D8 |
38 |
M |
2 |
Kidney |
Nephroblastoma |
– |
II |
T2N0M0 |
Malignant |
|
D9 |
39 |
F |
3 |
Kidney |
Nephroblastoma |
– |
I |
T1N0M0 |
Malignant |
|
D10 |
40 |
M |
13 |
Kidney |
Nephroblastoma |
– |
II |
T2N0M0 |
Malignant |
|
E1 |
41 |
M |
43 |
Cerebrum |
Glioblastoma of occipital lobe |
4 |
– |
– |
Malignant |
|
E2 |
42 |
F |
6 |
Cerebrum |
Glioblastoma of left occipital lobe |
4 |
– |
– |
Malignant |
|
E3 |
43 |
M |
19 |
Cerebrum |
Glioblastoma of interbrain |
4 |
– |
– |
Malignant |
|
E4 |
44 |
F |
65 |
Cerebrum |
Glioblastoma |
4 |
– |
– |
Malignant |
|
E5 |
45 |
M |
47 |
Cerebrum |
Glioblastoma of right frontal lobe |
4 |
– |
– |
Malignant |
|
E6 |
46 |
F |
52 |
Cerebrum |
Glioblastoma of right parietal lobe |
4 |
– |
– |
Malignant |
|
E7 |
47 |
M |
26 |
Cerebrum |
Glioblastoma of right frontal lobe |
4 |
– |
– |
Malignant |
|
E8 |
48 |
M |
47 |
Cerebrum |
Glioblastoma of left temporal lobe |
4 |
– |
– |
Malignant |
|
E9 |
49 |
F |
31 |
Cerebrum |
Glioblastoma of left occipital lobe |
4 |
– |
– |
Malignant |
|
E10 |
50 |
M |
40 |
Cerebrum |
Glioblastoma of right occipital lobe |
4 |
– |
– |
Malignant |
|
F1 |
51 |
M |
53 |
Cerebellum |
Medulloblastoma |
– |
– |
– |
Malignant |
|
F2 |
52 |
F |
47 |
Cerebellum |
Medulloblastoma |
– |
– |
– |
Malignant |
|
F3 |
53 |
M |
30 |
Cerebellum |
Medulloblastoma |
– |
– |
– |
Malignant |
|
F4 |
54 |
F |
8 |
Cerebellum |
Medulloblastoma |
– |
– |
– |
Malignant |
|
F5 |
55 |
F |
32 |
Cerebellum |
Medulloblastoma |
– |
– |
– |
Malignant |
|
F6 |
56 |
M |
11 |
Cerebellum |
Medulloblastoma of fourth ventricle |
– |
– |
– |
Malignant |
|
F7 |
57 |
F |
33 |
Cerebellum |
Medulloblastoma |
– |
– |
– |
Malignant |
|
F8 |
58 |
M |
44 |
Cerebellum |
Medulloblastoma |
– |
– |
– |
Malignant |
|
F9 |
59 |
M |
7 |
Cerebellum |
Medulloblastoma |
– |
– |
– |
Malignant |
|
F10 |
60 |
F |
16 |
Cerebellum |
Medulloblastoma |
– |
– |
– |
Malignant |
|
G1 |
61 |
M |
8 |
Cerebellum |
Medulloblastoma |
– |
– |
– |
Malignant |
|
G2 |
62 |
M |
3 |
Cerebrum |
Medulloblastoma |
– |
– |
– |
Malignant |
|
G3 |
63 |
F |
14 |
Cerebrum |
Medulloblastoma |
– |
– |
– |
Malignant |
|
G4 |
64 |
M |
14 |
Cerebrum |
Medulloblastoma |
– |
– |
– |
Malignant |
|
G5 |
65 |
M |
9 |
Cerebrum |
Medulloblastoma |
– |
– |
– |
Malignant |
|
G6 |
66 |
M |
2 |
Cerebrum |
Ependymoblastoma of occipitalia |
– |
– |
– |
Malignant |
|
G7 |
67 |
F |
39 |
Cerebrum |
Ependymoblastoma of posterior cranial fossa |
– |
– |
– |
Malignant |
|
G8 |
68 |
F |
15 |
Eyeball |
Retinoblastoma |
– |
IIc |
T3cN0M0 |
Malignant |
|
G9 |
69 |
M |
28 |
Eyeball |
Retinoblastoma |
– |
IIc |
T3cN0M0 |
Malignant |
|
G10 |
70 |
F |
22 |
Ovary |
Gynandroblastoma |
– |
– |
– |
Malignant |
|
H1 |
71 |
M |
40 |
Lymph node |
Normal lymph node tissue |
– |
– |
– |
Normal |
|
H2 |
72 |
F |
15 |
Lymph node |
Normal lymph node tissue |
– |
– |
– |
Normal |
|
H3 |
73 |
F |
50 |
Kidney |
Normal kidney tissue |
– |
– |
– |
Normal |
|
H4 |
74 |
F |
38 |
Kidney |
Normal kidney tissue |
– |
– |
– |
Normal |
|
H5 |
75 |
F |
2 |
Cerebrum |
Normal cerebrum tissue |
– |
– |
– |
Normal |
|
H6 |
76 |
M |
46 |
Cerebrum |
Normal cerebrum tissue |
– |
– |
– |
Normal |
|
H7 |
77 |
F |
8 |
Cerebellum |
Normal cerebellum tissue |
– |
– |
– |
Normal |
|
H8 |
78 |
F |
24 |
Cerebellum |
Normal cerebellum tissue |
– |
– |
– |
Normal |
|
H9 |
79 |
F |
18 |
Ovary |
Normal ovary tissue (sparse) |
– |
– |
– |
Normal |
|
H10 |
80 |
F |
20 |
Ovary |
Normal ovary tissue |
– |
– |
– |
Normal |
|
–
|
– |
M |
58 |
Skin |
Malignant melanoma (tissue marker) |
– |
|
|
Malignant |
† For precise diagnosis, refer to pathology description.
**The grade 1-3 (or I-III) in Pathology Diagnosis is equivalent to well-differentiated, moderately-differentiated or poorly differentiated, respectively, under microscope.
Grade 1 or well-differentiated: Cells appear normal and are not growing rapidly.
Grade 2 or moderately-differentiated: Cells appear slightly different than normal.
Grade 3 or poorly differentiated: Cells appear abnormal and tend to grow and spread more aggressively.
Grade 4 or undifferentiated: *(for certain tumors), features are not significantly distinguishing to make it look any different from undifferentiated cancers which occur in other organs.
TNM grading:
T - Primary tumor
Tx - Primary tumor cannot be assessed
T0 - No evidence of primary tumor
Tis - Carcinoma in situ; intraepithelial or invasion of lamina propria
T1 - Tumor invades submucosa
T2 - Tumor invades muscularis propria
T3 - Tumor invades through muscularis propria into subserosa or into non-peritonealized pericolic or perirectal tissues.
T4 - Tumor directly invades other organs or structures and/or perforate visceral peritoneum
N - Regional lymph nodes
Nx - Regional lymph nodes cannot be assessed
N0 - No regional lymph node metastasis
N1 - Metastasis in 1 to 3 regional lymph nodes
N2 - Metastasis in 4 or more regional lymph nodes
M - Distant metastasis
Mx - Distant metastasis cannot be assessed
M0 - No distant metastasis
M1 - Distant metastasis
|
|